newsfilter
← Latest News
GlobeNewswire·

Athenex Announces Receipt of Positive Nasdaq Listing Determination

BUFFALO, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of